查詢結果分析
相關文獻
- Recombinant Human Growth Hormone (Genotropin) in Treatment of Children With Growth Hormone Deficiency: The First Year Observation
- 基因工程與學術自由的保障
- Growth Hormone Therapy in Turner Syndrome
- 一個跨代的生命倫理思考:生殖細胞基因治療的規範形成
- 分子生物學與臨床醫學--分子醫學
- Linear Growth Response to Recombinant Human Growth Hormone in Children with Growth Hormone Deficiency
- Recombinant DNA Produced Somatropin in the Treatment of Prepubertal Growth Hormone Deficient Children
- 雷射耳穴治療脊髓損傷患者疼痛的立即效果
- 臺灣大學物理治療畢業生現況之研究
- 肺臟和心肺移植及其物理治療
頁籤選單縮合
題 名 | Recombinant Human Growth Hormone (Genotropin) in Treatment of Children With Growth Hormone Deficiency: The First Year Observation=基因工程生長激素治療生長激素缺乏兒童: 第一年觀察 |
---|---|
作 者 | 郭懷楓; | 書刊名 | 中華民國小兒科醫學會雜誌 |
卷 期 | 33:1 民81.01-02 |
頁 次 | 頁12-19 |
分類號 | 417.592 |
關鍵詞 | 基因工程; 生長激素; 治療; |
語 文 | 英文(English) |
中文摘要 | 五位生長激素缺乏的兒童經診斷確定後,開始接受爲期一年的生長激素治療,劑量爲每天每公斤體重0.1國際單位皮下注射。所有小朋友在身高生長速度,骨骼生長速度等指標均有明顯的進步,結果分別爲:身高生長速度增加7.86±2.00公分/年,骨齡平均增加0.80±0.16骨齡,治療過程中沒有任何不良反應發生。僅一名兒童治療後體內産生低效價抗生長激素抗體,但並未影響該名兒童之生長速度。 |
英文摘要 | Five prepubertal children with previously untreated growth hormone deficiency were enrolled in this trial and treated with authentic recombinant human growth hormone hGH, 0.1 IU/Kg/day, subcutaneously, for one year. All of the children markedly increased their growth rate; the height velocity increased from 3.4±0.7 cm/yr to 11.3±2.0 cm/yr during one year's treatment. The height-standard deviation score for chronological age increased from -4.03±0.52 to -2.70±0.68. The bone age increased from 5.6±1.5 year before treatment to 6.4±1.6 years after one-year treatment. Only one child acquired low titer anti-hGH antibodies during the course of treatment (1:2 to 1:6). No untoward symptoms were complained of by these children and no biochemical abnormalities occurred except transient subclinical hypothyroidism in one child during the treatment course. |
本系統中英文摘要資訊取自各篇刊載內容。